Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases
Research on Key Technologies of Intelligent Auxiliary Diagnosis for Multiple Eye Diseases Based on Multimodal Ultra-High-Speed SS-OCT/OCTA
1 other identifier
observational
5,000
0 countries
N/A
Brief Summary
Aiming at the problems of low image reading efficiency, crowded medical resources and fragmented cross-modal information of ophthalmic OCT and OCTA, a multimodal large model diagnostic framework for various diseases such as retinal diseases and optic nerve damage in glaucoma is constructed to fully explore the complementary information of various images such as SS-OCT structural images, SS-OCTA vascular images and optic nerve scans. Extract cross-modal joint features to improve the accuracy of automatic diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2025
CompletedFirst Posted
Study publicly available on registry
August 27, 2025
CompletedStudy Start
First participant enrolled
August 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
August 27, 2025
August 1, 2025
2.8 years
July 29, 2025
August 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
CMT
Central macular thickness measured on OCT
Baseline
Secondary Outcomes (1)
SS-OCT/OCTA images
Baseline
Interventions
There is no special intervention method
Eligibility Criteria
Patients diagnosed as macular degeneration, diabetic macular edema, retinal vein obstructive macular edema, high myopia, glaucoma or other clearly diagnosed ophthalmic diseases.
You may qualify if:
- Diagnosed as macular degeneration, diabetic macular edema, retinal vein obstructive macular edema, high myopia, glaucoma or other clearly diagnosed ophthalmic diseases. The SS-OCT/SS-OCTA images of the patient are clear.
You may not qualify if:
- The image quality is poor and difficult to analyze due to reasons such as refractive media opacity and poor coordination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Hospitallead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2025
First Posted
August 27, 2025
Study Start
August 30, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
August 27, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share